Paritaprevir/ritonavir, ombitasvir, and dasabuvir for treatment of recurrent hepatitis C virus infection in the human immunodeficiency virus coinfected liver transplant recipient. Issue 2 (February 2016) - Sollima, Salvatore; Milazzo, Laura; Torre, Alessandro; Calvi, Elisa; Regalia, Enrico; Antinori, Spinello